Software and Datasets
INDIGO
INDIGO (INferring Drug Interactions using chemoGenomics and Orthology) algorithm predicts how antibiotics prescribed in combinations will inhibit bacterial growth. INDIGO leverages genomics and drug-interaction data in the model organism – E. coli, to facilitate the discovery of effective combination therapies in less-studied pathogens, such as M. tuberculosis. [Download INDIGO algorithm] (Ref: Chandrasekaran et al. Molecular Systems Biology 2016) [INDIGO Tutorial] [Download INDIGO model for Tuberculosis INDIGO-MTB]
MAGENTA
MAGENTA (Metabolism And GENomics-based Tailoring of Antibiotic regimens) predicts the impact of pathogen environment on antibiotic potency. MAGENTA uses chemogenomic data to predict synergistic or antagonistic drug-interactions in different metabolic environments. [Download MAGENTA software and datasets] (Ref: Cokol, Li and Chandrasekaran, Plos Computational Biology 2018) [Get latest version of MAGENTA]
CARAMeL
The Condition-specific Antibiotic Regimen Assessment using Mechanistic Learning (CARAMeL) algorithm can predict how drug interactions are influenced by pathogen metabolic heterogeneity due to both extrinsic environment and intrinsic variation in a population [CARAMEL code] (Ref: Chung and Chandrasekaran, PNAS Nexus 2022)
ASTRIX
ASTRIX (Analyzing Subsets of Transcriptional Regulators Influencing eXpression) uses gene expression data to identify regulatory interactions between transcription factors and their target genes. Ref: Chandrasekaran et al, PNAS, 2011. [Download ASTRIX algorithm and example data]
Dynamic flux activity (dfa)
The DFA approach uses genome-scale metabolic network models to infer the activity of metabolic reactions from time-course metabolomics data. This approach was shown to accurately predict metabolic differences between different embryonic- and induced- pluripotent stem cells. Ref: Chandrasekaran et al, Cell Reports, 2017. [Download DFA source code; Tutorial data]
PROM
PROM (Probabilistic Regulation of Metabolism) enables the quantitative integration of regulatory and metabolic networks to build genome-scale integrated metabolic–regulatory models [Download PROM models for E. coli and Mycobacterium tuberculosis; latest version of the PROM algorithm] (Ref: Chandrasekaran and Price, PNAS 2010)
METABOLISM - EPIGENOME MODEL
The epigenome-scale metabolic network model (EGEM) predicts the impact of metabolic alterations on histone acetylation, a central epigenome modification that impacts gene expression. Data from Shen et al, Genome Biology, 2019. [Download Metabolism-Epigenome model]
METONCOFIT
METONCOFIT uses genome-scale metabolic modeling and machine learning to discover common properties of metabolic genes that are frequently mutated in a specific cancer. It quantifies the relative importance of various metabolic features in predicting metabolic dysregulation using gene expression, copy number variation, and survival data. [Supplementary website] (Ref: Oruganty et al, Cancer & Metabolism, 2020)
CAROM
CAROM identifies common properties of metabolic genes that are targets of regulation by phosphorylation and acetylation. CAROM uses genome-scale metabolic modeling and machine learning to predict regulation targets in new conditions based on various metabolic features of enzymes. [Source code] (Ref: Smith et al, iScience, 2022)
GEMINI
GEMINI (Gene Expression and Metabolism Integrated for Network Inference) directly connects regulatory interactions to observable phenotypes and allows rapid assessment of inferred regulatory interactions using a metabolic network [GEMINI algorithm implementation and Data] (Ref: Chandrasekaran and Price, Plos Computational Biology 2013) [GEMINI tutorial data]